Myeloid-derived suppressor cells function as novel osteoclast progenitors enhancing bone loss in breast cancer.
about
Bone metastases: When and how lung cancer interacts with boneImmune regulation of bone metastasisMyeloid-derived suppressor cells as therapeutic target in hematological malignanciesMyeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implicationsRegulation of tumor metastasis by myeloid-derived suppressor cellsBone specific immunity and its impact on metastasisMyeloid-derived suppressor cells in the tumor microenvironment: expect the unexpectedOrchestration of angiogenesis by immune cellsThe innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy.MicroRNAs in the control of metastatic bone disease.Dissecting the role of bone marrow stromal cells on bone metastases.Osteoclasts: more than 'bone eaters'.Extracellular Membrane Vesicles Derived from 143B Osteosarcoma Cells Contain Pro-Osteoclastogenic Cargo: A Novel Communication Mechanism in Osteosarcoma Bone Microenvironment.Human osteoclasts are inducible immunosuppressive cells in response to T cell-derived IFN-γ and CD40 ligand in vitroTungsten targets the tumor microenvironment to enhance breast cancer metastasisTasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine modelsGranulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastasesBone-immune cell crosstalk: bone diseases.Bone marrow as a metastatic niche for disseminated tumor cells from solid tumors.Myeloid lineage skewing due to exacerbated NF-κB signaling facilitates osteopenia in Scurfy mice.Cysteine cathepsin activity suppresses osteoclastogenesis of myeloid-derived suppressor cells in breast cancerA core of kinase-regulated interactomes defines the neoplastic MDSC lineage.Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib Treatment.Osteoclasts-Key Players in Skeletal Health and Disease.Myeloid-derived suppressor cells as osteoclast progenitors: a novel target for controlling osteolytic bone metastasisDown-regulation of PLCγ2-β-catenin pathway promotes activation and expansion of myeloid-derived suppressor cells in cancer.Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma.Location of tumor affects local and distant immune cell type and numberContributions of the host microenvironment to cancer-induced bone disease.Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies.Integrating new discoveries into the "vicious cycle" paradigm of prostate to bone metastases.Bone and the innate immune system.Induction of osteoclast progenitors in inflammatory conditions: key to bone destruction in arthritis.Immunological dysregulation in multiple myeloma microenvironment.Myeloid-derived suppressor cells: their role in the pathophysiology of hematologic malignancies and potential as therapeutic targets.Myeloid-derived suppressor cells in multiple myeloma: pre-clinical research and translational opportunities.The Impact of Immune System in Regulating Bone Metastasis Formation by Osteotropic Tumors.The Bone Microenvironment: a Fertile Soil for Tumor Growth.One microenvironment does not fit all: heterogeneity beyond cancer cells.Bone marrow myeloid cells in regulation of multiple myeloma progression.
P2860
Q26823287-D69821C3-1366-4B96-9B24-A59BD712CC0CQ27005871-3BAE8220-1CE1-4AE1-8DF5-077CFC268928Q27010234-458F6FBE-E671-49A9-95BB-972C8F193642Q27014189-EDB812E2-5D0B-4E3A-A07D-CD1AB330B639Q27022125-AA24080C-9420-4907-95CF-072A898740F0Q27022883-1A865ECA-9D31-4C4C-8BD4-E021A3713236Q28084627-5A5964E0-E0FD-4F90-A671-28CB8A2B6656Q28389236-F1E8F583-333A-43D7-BB1A-37E9A9C935BAQ33660069-ACAF0406-1760-4698-93C2-2161136C6945Q33821326-D2B7C139-894A-49F8-B56F-BE3AF2641A56Q33904588-551D71A9-B9C0-4843-B92C-6451EEB4F8D2Q33993757-49387851-FB6B-4625-B75E-7F0C15D7FBA0Q34092199-E53805FB-2967-49C2-9F99-62BF17E1ED4EQ34674972-86C21A11-F1DC-4CE5-82B8-92FB19F1C087Q34760260-1602157B-2E0C-4CAD-84F3-B593713771B9Q35071167-3CF60BD3-4CED-43D2-8160-6AE65DB57000Q35549911-0221B6D8-8D74-45EA-92AD-E98FB3FBDBDEQ35592362-CA100FCB-3375-46A9-9BC9-C2ECA2E2CC4CQ35632622-1790E718-1E80-4653-AD97-E22601C3FF24Q36293309-71966ECD-C79A-4056-91FB-5B0AD9B85F48Q36413686-43100799-49D8-47A5-9F4A-BD6B2AA3D24FQ36413721-FD5FF646-0C46-42DF-A875-700852674767Q36918248-4F636D82-B738-465F-B2DA-2E2196620568Q37036135-FD90B66F-22E6-4A1F-8B01-DE65932C8390Q37067495-19633EBF-8548-4B02-A0DF-AC3CE27253BBQ37246466-3C5FBC2A-E14C-417C-A479-340E120075D7Q37437357-D33787C6-36AF-40F8-BE47-325B70C5C2E5Q37660747-E31FE8D0-BF65-481C-A728-AF559B5D0495Q37663962-77DD601F-29BE-4BE5-A387-AD762327AC8DQ37665711-DE50A273-B244-41D4-9050-A6D0A645E126Q38177689-9625E0EA-4F2D-4096-8E83-819F6693C169Q38185586-F0C76C01-5CCB-441A-A766-43802AC4F96BQ38218977-6A027DE8-BEE4-4C6D-83C3-7F6A072A359BQ38228353-AF8C9FCE-3E05-4791-BA37-E330FB358E98Q38269370-B48B0342-CB19-48F1-A5AE-A65F31CAA8EAQ38299932-FC9276B3-B0B2-4291-B421-5ABD3D45F2A8Q38524842-12610305-B2DD-4B06-963C-961724BE1102Q38851859-049D4BF0-6C02-46E1-A60F-1BBF3A70D50AQ39011826-E2B6E1C8-7A77-400C-B929-B13E9D9470DEQ39220773-9C84DF6D-192D-45C8-88A6-CF60F46E9AF0
P2860
Myeloid-derived suppressor cells function as novel osteoclast progenitors enhancing bone loss in breast cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Myeloid-derived suppressor cel ...... ng bone loss in breast cancer.
@ast
Myeloid-derived suppressor cel ...... ng bone loss in breast cancer.
@en
type
label
Myeloid-derived suppressor cel ...... ng bone loss in breast cancer.
@ast
Myeloid-derived suppressor cel ...... ng bone loss in breast cancer.
@en
prefLabel
Myeloid-derived suppressor cel ...... ng bone loss in breast cancer.
@ast
Myeloid-derived suppressor cel ...... ng bone loss in breast cancer.
@en
P2093
P2860
P1433
P1476
Myeloid-derived suppressor cel ...... ng bone loss in breast cancer.
@en
P2093
Anandi Sawant
Brittney A Harris
Carnella M Lee
Jessy Deshane
Joel Jules
Selvarangan Ponnazhagan
P2860
P304
P356
10.1158/0008-5472.CAN-12-2202
P407
P577
2012-12-14T00:00:00Z